Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients


MERSİN S., GEDÜK A., MEHTAP Ö., TARKUN P., ÜNAL S., POLAT M. G. , ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.38, no.3, pp.211-217, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.4274/tjh.galenos.2021.2020.0555
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.211-217
  • Keywords: Bortezomib, Multiple myeloma, Equivalent, CYCLOPHOSPHAMIDE, DEXAMETHASONE, COMBINATION, EFFICACY
  • Kocaeli University Affiliated: Yes

Abstract

Objective: Constantly increasing health expenditures lead to the use of generic molecules and generic versions of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects, and reliability of generic bortezomib in newly diagnosed multiple myeloma (MM) patients.